127 related articles for article (PubMed ID: 8604887)
1. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
Friedman M; Venkatesan TK; Caldarelli DD
Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
[TBL] [Abstract][Full Text] [Related]
2. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
[TBL] [Abstract][Full Text] [Related]
3. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
Flaitz CM; Nichols CM; Hicks MJ
Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
[TBL] [Abstract][Full Text] [Related]
4. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
McCormick SU
J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
[TBL] [Abstract][Full Text] [Related]
5. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
[TBL] [Abstract][Full Text] [Related]
6. Intralesional vinblastine therapy for Kaposi's sarcoma of the epiglottis.
Tami TA; Sharma PK
Otolaryngol Head Neck Surg; 1995 Sep; 113(3):283-5. PubMed ID: 7675491
[No Abstract] [Full Text] [Related]
7. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
[TBL] [Abstract][Full Text] [Related]
8. Local treatment of AIDS-associated bulky Kaposi's sarcoma in the head and neck region.
Shimomura S; Kikuchi Y; Oka S; Ishitoya J
Auris Nasus Larynx; 2000 Oct; 27(4):335-8. PubMed ID: 10996492
[TBL] [Abstract][Full Text] [Related]
9. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Turiansky G; Wagner KF
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the treatment of Kaposi's sarcoma with vinblastine in Togo: a study of 23 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Balaka A; Pitché P; Tchangaï-Walla K
Bull Soc Pathol Exot; 2011 Dec; 104(5):339-41. PubMed ID: 21359830
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
Epstein JB
Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen.
Kaplan L; Abrams D; Volberding P
Cancer Treat Rep; 1986 Sep; 70(9):1121-2. PubMed ID: 3742492
[TBL] [Abstract][Full Text] [Related]
14. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
[TBL] [Abstract][Full Text] [Related]
15. Treatment modalities for intraoral Kaposi's sarcoma: report of case.
Chockley B; Coke JM
Spec Care Dentist; 1991; 11(6):231-3. PubMed ID: 1839938
[TBL] [Abstract][Full Text] [Related]
16. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.
Nasti G; Errante D; Talamini R; Rizzardini G; Fasan M; Landonio G; Zeroli C; Chichino G; Nigra E; Vaccher E; Tirelli U
J Clin Oncol; 2000 Apr; 18(7):1550-7. PubMed ID: 10735904
[TBL] [Abstract][Full Text] [Related]
18. Evidence of activity of vinorelbine in patients with previously treated AIDS-associated Kaposi's sarcoma.
Errante D; Fasan M; Rizzardini G; Landonio G; Pagani L; Zeroli C; Tirelli U
AIDS; 1996 Dec; 10(14):1742-3. PubMed ID: 8970700
[No Abstract] [Full Text] [Related]
19. [Intralesional vinblastine in the treatment of Kaposi's sarcoma. Presentation of a case].
Gaglioti D; Ficarra G; Nardi P
Minerva Stomatol; 1989 Sep; 38(9):955-7. PubMed ID: 2811811
[TBL] [Abstract][Full Text] [Related]
20. [The laryngeal involvement in Kaposi's sarcoma in the acquired immunodeficiency syndrome].
Olmo A; Vilaseca I; Moragas M; Pérez J; Blanch JL; Avellaneda R; Traserra J
An Otorrinolaringol Ibero Am; 1993; 20(6):589-97. PubMed ID: 8135335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
